Title :

French guidelines on TIPS: Indications and modalities.

Author(s) :

Larrue, H. [Auteur]
Université Toulouse III Paul Sabatier - Faculté de médecine Purpan [UTPS]
Allaire, M. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Weil-Verhoeven, D. [Auteur]
Service d'Hépatologie [CHRU Besançon]
Barge, S. [Auteur]
Centre Hospitalier Intercommunal de Créteil [CHIC]
Thabut, D. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Payance, A. [Auteur]
Service d’Hépatologie [Hôpital Beaujon]
Moga, L. [Auteur]
Hôpital Beaujon [AP-HP]
Jézéquel, C. [Auteur]
Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
Artru, F. [Auteur]
Service des maladies du foie [CHU Rennes]
Archambeaud, I. [Auteur]
Centre Hospitalier Universitaire de Nantes = Nantes University Hospital [CHU Nantes]
Elkrief, L. [Auteur]
Centre Hospitalier Régional Universitaire de Tours [CHRU Tours]
Oberti, F. [Auteur]
Centre Hospitalier Universitaire d'Angers [CHU Angers]
Roux, C. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Laleman, W. [Auteur]
University Hospital Gasthuisberg [Leuven]
Rudler, M. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Dharancy, Sebastien [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Laborde, N. [Auteur]
Service Anesthésie - Hôpital des enfants [CHU Toulouse]
Minello, A. [Auteur]
CHU Dijon
Mouillot, T. [Auteur]
Service d'Endocrinologie, Diabétologie et Maladies Métaboliques (CHU de Dijon)
Desjonquères, E. [Auteur]
Université Sorbonne Paris Nord
Wandji, Line [Auteur]
Institute for Translational Research in Inflammation - U 1286 [INFINITE]
Bourlière, M. [Auteur]
Hôpital Saint-Joseph [Marseille]
Ganne-Carrié, N. [Auteur]
Centre de Recherche des Cordeliers [CRC (UMR_S_1138 / U1138)]
Bureau, C. [Auteur]
Université Toulouse III - Paul Sabatier [UT3]

Journal title :

Liver Int

Abbreviated title :

Liver Int

Publication date :

2024-06-01

ISSN :

1478-3231

English keyword(s) :

cirrhosis
guidelines
portal hypertension
TIPS

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

Transjugular intrahepatic portosystemic shunt (TIPS) has become essential in the treatment or prevention of portal hypertension-related complications. In the early 1990s, the primary indication was refractory bleeding. It ...
Show more >Transjugular intrahepatic portosystemic shunt (TIPS) has become essential in the treatment or prevention of portal hypertension-related complications. In the early 1990s, the primary indication was refractory bleeding. It is now proposed for the treatment of ascites for the prevention of bleeding and in patients with vascular diseases of the liver. Thus, there are a growing number of patients being treated with TIPS all over the world. The broadening of indications, the involvement of multiple stakeholders, the need for an accurate selection, the positioning in relation to transplantation and the lack of standardization in pre-therapeutic assessment, in the procedure itself and in the follow-up have led the board of the French Association for the Study of the Liver to establish recommendations.Show less >

Language :

Anglais

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

Université de Lille
Inserm
CHU Lille

Collections :

• Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286

Submission date :

2024-06-25T21:11:10Z
2024-08-28T08:00:49Z